Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV
Nima Hemmat, Zahra Asadzadeh, Noora Karim Ahangar, et al.
Archives of Virology (2021) Vol. 166, Iss. 3, pp. 675-696
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention
Ekta Shirbhate, Jaiprakash Pandey, Vijay K. Patel, et al.
Pharmacological Reports (2021) Vol. 73, Iss. 6, pp. 1539-1550
Open Access | Times Cited: 111
Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases
Sareh Kakavandi, Iman Zare, Maryam Vaezjalali, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 67
Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets
Masoumeh Farahani, Zahra Niknam, Leila Mohammadi Amirabad, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112420-112420
Open Access | Times Cited: 102
Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC
Tahereh Donyavi, Farah Bokharaei-Salim, Hossein Bannazadeh Baghi, et al.
International Immunopharmacology (2021) Vol. 97, pp. 107641-107641
Open Access | Times Cited: 92
Role of miR-2392 in driving SARS-CoV-2 infection
J. Tyson McDonald, Francisco J. Enguita, Deanne Taylor, et al.
Cell Reports (2021) Vol. 37, Iss. 3, pp. 109839-109839
Open Access | Times Cited: 81
Viral coinfections in COVID‐19
Parisa Shiri Aghbash, Narges Eslami, Milad Shirvaliloo, et al.
Journal of Medical Virology (2021) Vol. 93, Iss. 9, pp. 5310-5322
Open Access | Times Cited: 67
Kinases as Potential Therapeutic Targets for Anti-coronaviral Therapy
Thanigaimalai Pillaiyar, Stefan Laufer
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 2, pp. 955-982
Closed Access | Times Cited: 61
The IGF-1 Signaling Pathway in Viral Infections
Agata Józefiak, Magdalena Larska, Małgorzata Pomorska‐Mól, et al.
Viruses (2021) Vol. 13, Iss. 8, pp. 1488-1488
Open Access | Times Cited: 57
An inhaled bioadhesive hydrogel to shield non-human primates from SARS-CoV-2 infection
Xuan Mei, Junlang Li, Zhenzhen Wang, et al.
Nature Materials (2023)
Open Access | Times Cited: 38
Covid-19 and development of heart failure: mystery and truth
Hope Onohuean, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2021) Vol. 394, Iss. 10, pp. 2013-2021
Open Access | Times Cited: 56
Endoplasmic reticulum stress and NF‐kB activation in SARS‐CoV‐2 infected cells and their response to antiviral therapy
Desireé Bartolini, Anna Maria Stabile, Carmine Vacca, et al.
IUBMB Life (2021) Vol. 74, Iss. 1, pp. 93-100
Open Access | Times Cited: 41
The role of antigen-presenting cells in the pathogenesis of COVID-19
Rana Farzi, Parisa Shiri Aghbash, Narges Eslami, et al.
Pathology - Research and Practice (2022) Vol. 233, pp. 153848-153848
Open Access | Times Cited: 30
Severe acute respiratory syndrome coronaviruses contributing to mitochondrial dysfunction: Implications for post-COVID complications
Shama Prasada Kabekkodu, Sanjiban Chakrabarty, Pradyumna Jayaram, et al.
Mitochondrion (2023) Vol. 69, pp. 43-56
Open Access | Times Cited: 21
The Role of the Nuclear Factor-Kappa B (NF-κB) Pathway in SARS-CoV-2 Infection
Periyanaina Kesika, Subramanian Thangaleela, S. Natarajan, et al.
Pathogens (2024) Vol. 13, Iss. 2, pp. 164-164
Open Access | Times Cited: 6
Weighted Gene Co-Expression Network Analysis Combined with Machine Learning Validation to Identify Key Modules and Hub Genes Associated with SARS-CoV-2 Infection
Hassan Karami, Afshin Derakhshani, Mohammad GhasemiGol, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 16, pp. 3567-3567
Open Access | Times Cited: 39
p53/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics)
Daniela Milani, Lorenzo Caruso, Enrico Zauli, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 27
TP53 Gene Therapy as a Potential Treatment for Patients with COVID-19
Joe B. Harford, Sang Soo Kim, Kathleen F. Pirollo, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 739-739
Open Access | Times Cited: 25
Selinexor and COVID-19: The Neglected Warden
Gomaa Mostafa‐Hedeab, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 25
Multi-omic comparative analysis of COVID-19 and bacterial sepsis-induced ARDS
Richa Batra, William Whalen, Sergio Alvarez-Mulett, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 9, pp. e1010819-e1010819
Open Access | Times Cited: 25
How Aging and Oxidative Stress Influence the Cytopathic and Inflammatory Effects of SARS-CoV-2 Infection: The Role of Cellular Glutathione and Cysteine Metabolism
Francesco Galli, Giada Marcantonini, Daniela Giustarini, et al.
Antioxidants (2022) Vol. 11, Iss. 7, pp. 1366-1366
Open Access | Times Cited: 24
Woodsmoke particle exposure prior to SARS-CoV-2 infection alters antiviral response gene expression in human nasal epithelial cells in a sex-dependent manner
Stephanie A. Brocke, Grant T. Billings, Sharon Taft-Benz, et al.
AJP Lung Cellular and Molecular Physiology (2022) Vol. 322, Iss. 3, pp. L479-L494
Open Access | Times Cited: 22
Roles of p53-Mediated Host–Virus Interaction in Coronavirus Infection
Xue Wang, Yi Liu, Kaiyuan Li, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6371-6371
Open Access | Times Cited: 13
Screening of drug databank against WT and mutant main protease of SARS-CoV-2: Towards finding potential compound for repurposing against COVID-19
Tanuj Sharma, Mohammed Abohashrh, Mohammad Hassan Baig, et al.
Saudi Journal of Biological Sciences (2021) Vol. 28, Iss. 5, pp. 3152-3159
Open Access | Times Cited: 25
Blue Biotechnology: Computational Screening of Sarcophyton Cembranoid Diterpenes for SARS-CoV-2 Main Protease Inhibition
Mahmoud A. A. Ibrahim, Alaa H. M. Abdelrahman, Mohamed A. M. Atia, et al.
Marine Drugs (2021) Vol. 19, Iss. 7, pp. 391-391
Open Access | Times Cited: 25
Macrophage Activation Syndrome and COVID 19: Impact of MAPK Driven Immune-Epigenetic Programming by SARS-Cov-2
Roshan Kumar Roy, Uttam Sharma, Mishi Kaushal Wasson, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top